Premium
US-headquartered private equity giant The Carlyle Group has walked away with modest returns by selling a bulk of its stake in pathology chain operator Metropolis Healthcare Ltd. Carlyle sold about 6.55 million shares, or a 13.05% stake, in the company on Wednesday for Rs 757 crore ($99.1 million at current exchange ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
